These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33984893)

  • 1. Low immunity against vaccine preventable diseases in Turkish HIV cohort.
    Candevir A; Kuşcu F; Yıldırım F; Kömür S; Şentürk GÇ; İnal AS; Eser F; Çetiner S; Kurtaran B; Taşova Y
    Turk J Med Sci; 2021 Oct; 51(5):2311-2317. PubMed ID: 33984893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
    AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland.
    Kerr C; Kelleher M; Coughlan S; Crowley B; O'Reilly EJ; Bergin C
    BMC Infect Dis; 2022 Jun; 22(1):582. PubMed ID: 35768790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Maltezou HC; Karantoni H; Petrikkos P; Georgota P; Katerelos P; Liona A; Tsagarakis S; Theodoridou M; Hatzigeorgiou D
    Vaccine; 2020 Jan; 38(5):1181-1185. PubMed ID: 31761499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
    BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.
    Schwarze-Zander C; Draenert R; Lehmann C; Stecher M; Boesecke C; Sammet S; Wasmuth JC; Seybold U; Gillor D; Wieland U; Kümmerle T; Strassburg CP; Mankertz A; Eis-Hübinger AM; Jäger G; Fätkenheuer G; Bogner JR; Rockstroh JK; Vehreschild JJ
    Epidemiol Infect; 2017 Jan; 145(2):236-244. PubMed ID: 27780480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
    Karadeniz A; Akduman Alaşehir E
    J Infect Public Health; 2020 Apr; 13(4):480-484. PubMed ID: 32113699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK; Chiu YL; Wilkin T
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain.
    Norman FF; Comeche B; Martínez-Lacalzada M; Pérez-Molina JA; Gullón B; Monge-Maillo B; Chamorro S; López-Vélez R
    J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33611577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Laws HJ; Calaminus G; Göbel U
    Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Fioredda F; Giacchino M; Castagnola E
    Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union.
    Hurie MB; Gennis MA; Hernandez LV; Dindzans VJ; Davis JP
    JAMA; 1995 Mar 22-29; 273(12):954-6. PubMed ID: 7884955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
    PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.
    Ghafoori F; Mokhtari-Azad T; Foroushani AR; Farahmand M; Shadab A; Salimi V
    BMC Infect Dis; 2024 Jul; 24(1):696. PubMed ID: 38997625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.